Hyperbaric oxygen therapy in chronic stable... (1986 study) Skip to main content
RCT Neurology 1986

Hyperbaric oxygen therapy in chronic stable multiple sclerosis: double-blind study.

Harpur GD, Suke R, Bass BH, Bass MJ, Bull SB, Reese L, et al., Neurology, 1986

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers tested whether hyperbaric oxygen treatment helped people with long-standing, stable multiple sclerosis (MS) by comparing it with a placebo in a double-blind trial.

What They Found

In this randomized, double-blind, placebo-controlled trial of 82 patients with chronic stable MS, hyperbaric oxygen therapy produced no significant difference from placebo on disability scores, magnetic resonance imaging, or evoked potentials. Forty-one patients received 20 consecutive daily treatments of 100% oxygen, followed by 7 booster treatments over the next 6 months. The other 41 patients received "air" (12.5% oxygen at 1.75 atmospheres absolute). The groups did not differ on the Extended Kurtzke Disability scores or Kurtzke Functional scores after the first 20 treatments or after the boosters. The authors concluded that hyperbaric oxygen is not effective in treating chronic stable MS.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract reports only patients with chronic stable MS, so the findings do not cover other types or stages of the disease, and it gives no details on side effects or on how long patients were followed after the booster treatments.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Neurological
Source Pubmed
PubMed ID 3520382
Year Published 1986
Journal Neurology
MeSH Terms Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Evoked Potentials, Auditory; Evoked Potentials, Visual; Humans; Hyperbaric Oxygenation; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Random Allocation

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology